A groundbreaking study using AI has revealed how ME/CFS disrupts critical connections between the immune system, gut microbiome, and metabolism. The new platform, BioMapAI, achieved 90% accuracy in identifying ME/CFS patients based on stool, blood, and symptom data—offering long-overdue validation for millions living with this debilitating illness.